Sentinel Lymph Node Mapping Identifies Variable Cervical Drainage and Metastatic Nodes Outside Traditional Sampling Sites in Canine Oromaxillofacial Tumours
Veterinary and Comparative Oncology · 2026-12 · 24 (4) · 732-744
DOI: 10.1111/vco.70090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 10.07.2026. Verfasst von Emilia Chrostek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA. Hauptthemen laut MEDLINE: Dog Diseases, Sentinel Lymph Node Biopsy, Mouth Neoplasms, Sentinel Lymph Node. Die Arbeit nennt 41 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Sentinel lymph node mapping (SLNM) has emerged as a key technique to guide decisions regarding nodal extirpation in dogs with oromaxillofacial tumours. The primary aims of this retrospective study were to describe the clinical utility of indirect computed tomographic lymphangiography (ICTL) for SLNM in a large cohort of dogs, characterise variability in SLN drainage patterns by tumour location, and describe the distribution of metastatic lymph nodes (LNs) identified by SLNM guided cytology or pathology. SLN locations, cytology, and available histopathology were reported as descriptive data. ICTL data were evaluated for 77 oromaxillofacial tumours in 74 dogs. A median of 2 SLNs were identified per ICTL dataset with 92% having at least one SLN identified. The ipsilateral mandibular lymphocentrum was the most common drainage basin; however, contralateral or bilateral drainage was frequent, occurring in over 55% of rostral tumours. Lateralized tumours were associated with a higher frequency of ipsilateral mandibular SLN identification compared with non‐lateralized tumours ( p = 0.0009). Of 68 dogs with malignant tumours, 10 (15%) had LN metastasis. Metastasis occurred in the SLN ( n = 8), outside the SLN ( n = 1), and in one dog without any identifiable SLNs. In 4 dogs (40%), metastasis extended beyond the ipsilateral lateral MLN; 3 dogs had metastasis exclusively in the medial retropharyngeal LNs. Among dogs with paired cytology and pathology, the false‐negative rate of SLN cytology was 6.9%, potentially offering a low‐morbidity screening method prior to LN extirpation. Future studies should seek to evaluate how SLNM with guided LN sampling influences patient outcomes, given its clinical feasibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
- Department of Radiation Oncology, Medical School, University of Minnesota, Minneapolis, Minnesota, USA.
- Fission Veterinary Teleradiology, Brooklyn, New York, USA.
ORCID-Profile: Emilia Chrostek, Jessica Lawrence
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Chrostek, E., Lawrence, J., Arzi, B., Stewart, N., & Goldschmidt, S. (2026). Sentinel Lymph Node Mapping Identifies Variable Cervical Drainage and Metastatic Nodes Outside Traditional Sampling Sites in Canine Oromaxillofacial Tumours. Veterinary and Comparative Oncology, 24(4), 732-744. https://doi.org/10.1111/vco.70090
Vancouver
Chrostek E, Lawrence J, Arzi B, Stewart N, Goldschmidt S. Sentinel Lymph Node Mapping Identifies Variable Cervical Drainage and Metastatic Nodes Outside Traditional Sampling Sites in Canine Oromaxillofacial Tumours. Veterinary and Comparative Oncology. 2026;24(4):732-744. doi:10.1111/vco.70090
BibTeX
@article{Chrostek2026,
author = {Chrostek, Emilia and Lawrence, Jessica and Arzi, Boaz and Stewart, Nikia and Goldschmidt, Stephanie},
title = {Sentinel Lymph Node Mapping Identifies Variable Cervical Drainage and Metastatic Nodes Outside Traditional Sampling Sites in Canine Oromaxillofacial Tumours},
journal = {Veterinary and Comparative Oncology},
year = {2026},
volume = {24},
number = {4},
pages = {732--744},
doi = {10.1111/vco.70090}
}
EUVIMED